FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p–CCNG1 interaction network

Chemotherapy resistance is still a key hurdle in current hepatocellular carcinoma (HCC) treatment. Therefore, clarifying the molecular mechanisms contributing to this acquired resistance is urgent for the effective treatment of liver cancer. In this research, we observed that lncRNA FAM225A expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan-Tong, Liu, Guo-Qing, Huang, Jing-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744609/
https://www.ncbi.nlm.nih.gov/pubmed/33245102
http://dx.doi.org/10.1042/BSR20202054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744609/
https://www.ncbi.nlm.nih.gov/pubmed/33245102
http://dx.doi.org/10.1042/BSR20202054

Ejemplares similares